Related Experiment Video
Updated: Jun 18, 2026
08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
[Ocular neuromyotonia--clinical appearance and thoughts on pathogenesis]
1Augenklinik, HELIOS Kliniken Schwerin, Wismarsche Strasse 393-397, Schwerin. T.Wermund@gmx.de
Klinische Monatsblatter Fur Augenheilkunde
|November 17, 2009
Summary
Ocular neuromyotonia (ONM) causes temporary double vision due to abnormal eye muscle activity, often after radiation. Carbamazepine is an effective treatment for this rare neurogenic motility disorder.
Area of Science:
- Neuroscience
- Ophthalmology
Context:
- Ocular neuromyotonia (ONM) is a rare neurogenic disorder affecting eye movements.
- Patients experience recurrent, transient diplopia (double vision) due to sudden, painless eye deviation.
Purpose:
- To summarize the clinical presentation, pathophysiology, diagnosis, and treatment of ocular neuromyotonia.
- To provide an overview of this rare neurogenic disorder of ocular motility.
Summary:
- ONM involves high-frequency stimulation of an extraocular muscle, causing deviation in its direction of action.
- Potential causes include radiation therapy or cranial nerve compression.
- Pathophysiology may involve ephaptic transmission, potassium channel disturbances, or central neural reorganization.
- Diagnosis relies on clinical findings, electrophysiology, and neuroimaging to rule out compression.
- Carbamazepine is a common and effective therapy.
Impact:
- Enhances understanding of a rare neurogenic disorder affecting ocular motility.
- Informs clinical diagnosis and management strategies for ONM patients.
- Highlights the importance of neuroimaging in differential diagnosis.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...